SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Meitav Investment House Ltd.

Meitav Investment House Ltd. lowered its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 73.1% during the fourth quarter, Holdings Channel.com reports. The firm owned 17,414 shares of the exchange traded fund’s stock after selling 47,370 shares during the quarter. Meitav Investment House Ltd.’s holdings in SPDR S&P Biotech ETF were worth $1,568,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Golden State Wealth Management LLC acquired a new stake in SPDR S&P Biotech ETF in the fourth quarter valued at approximately $29,000. Avior Wealth Management LLC increased its position in shares of SPDR S&P Biotech ETF by 393.6% in the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after purchasing an additional 307 shares during the last quarter. Tidemark LLC raised its holdings in shares of SPDR S&P Biotech ETF by 101.5% in the 3rd quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock valued at $39,000 after purchasing an additional 199 shares in the last quarter. Quintet Private Bank Europe S.A. purchased a new stake in shares of SPDR S&P Biotech ETF during the 3rd quarter worth $40,000. Finally, Bank of Jackson Hole Trust acquired a new position in shares of SPDR S&P Biotech ETF during the fourth quarter worth $43,000.

SPDR S&P Biotech ETF Stock Performance

XBI opened at $92.53 on Thursday. The company has a market cap of $7.05 billion, a P/E ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a one year low of $81.14 and a one year high of $105.47. The business’s 50-day simple moving average is $91.42 and its 200-day simple moving average is $96.00.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.